# Experimental Vaccine for Prevention of Ebola Virus Infection

> **NCT00374309** · PHASE1 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 48 (—)

## Conditions studied

- Ebola Hemorrhagic Fever
- Ebola Virus Disease
- Ebola Virus Vaccines
- Envelope Glycoprotein, Ebola Virus
- Filovirus

## Interventions

- **DRUG:** VRC-EBOADV018-00-VP

## Key facts

- **NCT ID:** NCT00374309
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-09-05
- **Primary completion:** —
- **Final completion:** 2009-05-05
- **Target enrollment:** 48 (—)
- **Last updated:** 2017-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00374309

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00374309, "Experimental Vaccine for Prevention of Ebola Virus Infection". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00374309. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*